-

Executive War College: Virtual 2020 Conference Delivers Essential Information About COVID-19 Testing and Getting Paid for Claims

AUSTIN, Texas--(BUSINESS WIRE)--Clinical laboratories and anatomic pathology groups throughout the U.S. continue to fight to obtain adequate COVID-19 tests and collection kits, even as payers deny many legitimate testing claims. To help labs with both issues, the Virtual 2020 Executive War College on Laboratory Management kicked off Tuesday, August 4.

The clinical lab industry’s most important management meeting of the year, this is the first national conference to bring together almost 500 senior lab executives, lab administrators, pathologists, consultants, and IVD managers to share solutions and exchange knowledge about vendors able to deliver collection supplies, viral transport media, lab analyzers, COVID-19 tests, and reagents. Lab billing and collections experts will discuss why payers are denying COVID-19 and other test claims while sharing steps to take to get both COVID-19 and routine test claims paid.

Because lab professionals are working long hours to respond to the demand for COVID-19 testing, Virtual 2020 Executive War College will present one 60-minute general session and one 60-minute management master class each week for the next 12 weeks. Specialized topic sessions will also be provided to attendees. Live presentations allow participants to interact with speakers, with all sessions available to view on-demand, 24/7. Among the opening presentations:

  • Thursday, August 6, 1 PM - 2PM EDT
    Today’s Lab and Diagnostics Marketplace: Understanding the Reality and the Strategic Imperatives for All Labs and Diagnostic Companies: Lâle White, Chair/CEO, XIFIN
  • Tuesday, August 11, 1 PM – 2 PM EDT
    Anatomic Pathology During the Pandemic: Two Pathology Super Groups Share Their Setbacks, Strategies, Solutions, and Successes: Cory Roberts, President/CEO, ProPath and Patty Sipes, CEO, Incyte Diagnostics

Conference participants have the opportunity to network at virtual receptions, meet major vendors of COVID-19 instruments, tests, and supplies, and work with billing and collections consultants to enhance lab revenue.

“This is a prime opportunity to interact with, and learn from lab peers proven ways to deal with COVID-19 and get paid for lab tests and services,” stated Robert Michel. “The still-increasing demand for COVID-19 tests means that clinical labs can expect to be paid adequate reimbursement for these huge numbers of antibody tests. That added cash flow is badly needed at the moment and will help keep many labs financially solvent.”

For details on speakers and sessions and to register, visit https://www.executivewarcollege.com.

Contacts

Shelly Hatch, 512-264-7103

Industry:

The Dark Report

Release Versions
English

Contacts

Shelly Hatch, 512-264-7103

More News From The Dark Report

LabX Media Group Acquires The Dark Intelligence Group Inc, including The Dark Report and the Executive War College

AUSTIN, Texas--(BUSINESS WIRE)--The Dark Intelligence Group (TDIG) announced today that it has sold all its information services assets to LabX Media Group of Midland, Ontario, Canada. This sale involves all TDIG products and services, such as The Dark Report intelligence service, DarkDaily ebriefings, webinars, reports, and events, including the Executive War College on Diagnostic, Laboratory, and Pathology Management, the largest global conference on laboratory management for senior laborator...

Operationalizing FDA LDT Compliance: Expert Panel Reveals Essential Strategies and Actions for Meeting the 1st Reporting Milestone

AUSTIN, Texas--(BUSINESS WIRE)--Many clinical laboratories are now under the gun to achieve Phase One compliance with the Food and Drug Administration’s (FDA) LDT rule before the May 2025 deadline. Labs performing LDTs must take immediate action to protect their most important LDTs that improve patient care while generating substantial reimbursement. This is a high stakes situation for labs offering LDTs because they have only five months to secure their most valuable LDTs. To help labs underst...

Experts to Identify Essential Steps & Pitfalls to Help Clinical Laboratories Meet the Deadline to Comply with the FDA’s Laboratory Developed Test (LDT) Rule

AUSTIN, Texas--(BUSINESS WIRE)--With the first important deadline for compliance with the Food and Drug Administration’s (FDA) LDT rule only eight months away, experts urge clinical laboratories performing LDTs to take immediate action. This is essential to protect their most important LDTs that improve patient care while generating substantial reimbursement. The FDA’s final rule on Laboratory Developed Tests (LDTs) ushers in a radical overhaul of the FDA’s longstanding policy of enforcement di...
Back to Newsroom